Dean Li

Dean Li

Net worth: 25 M $ as of 2026-08-30

62 year
Health Technology
Consumer Services
Commercial Services

Profile

Founder of Hydra Biosciences, Inc., Navigen, Inc. and Recursion Pharmaceuticals, Inc., Dean Y. Li is an entrepreneur is on the board of Recursion Pharmaceuticals, Inc. and Executive Vice President for Merck & Co., Inc., Member of Association of American Physicians, Member of American Society for Clinical Investigation and Scientific Advisor at Navigen, Inc. In his past career Dr. Li was President & Chief Executive Officer of Arup Laboratories, Inc. Dean Y. Li received an undergraduate degree from The University of Chicago and a doctorate from Washington University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-04 94,431 ( 0% ) 14 M $ 2026-08-30
2026-06-30 3,316,377 ( 0.62% ) 11 M $ 2026-08-30

Dean Li active positions

CompaniesPositionStart
RECURSION PHARMACEUTICALS, INC. Founder 2013-11-03
MERCK & CO., INC. Corporate Officer/Principal 2016-12-31
Founder 2005-12-31
President 2020-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Dean Li

CompaniesPositionEnd
Chief Executive Officer 2016-07-31
Chief Tech/Sci/R&D Officer -
The University of Utah Health Sciences Center
Chief Tech/Sci/R&D Officer -
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
See the detail of Dean Li's experience

Training of Dean Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

The University of Utah Health Sciences Center

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!